quarter

NowVertical Group Reports Second Quarter 2025 Financial Results

TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSX-V: NOW) (“NOW” or the “Company”), a leader in AI-driven…

3 months ago

Crown Point Capital Rolls Out Global Investor Protection Program This Quarter

Zurich, Switzerland, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Crown Point Capital has officially announced the launch of its Global Investor Protection Program,…

4 months ago

Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum

Expenses significantly lower with expansion on multiple efforts; Q2 2025 loss from operations reduced to $5.4 million vs $8.6 million…

4 months ago

Foresight Reports Second Quarter 2025 andFirst Half 2025 Financial Results

NESS ZIONA, Israel, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the…

4 months ago

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

    - Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing…

4 months ago

UGRO CAPITAL ANNOUNCES FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2025

Reports AUM of INR 12,081 Cr, up 31% (YoY); Total Income of INR 421.8 Cr, up 40% (YoY); and PAT…

4 months ago

Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call

August 13, 2025 11:45 ET  | Source: Milestone Scientific, Inc. ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific…

4 months ago

Exicom Q1 FY26: Navigating a Soft Quarter with Clear Momentum for the Road Ahead

GURUGRAM, India, Aug. 13, 2025 /PRNewswire/ -- Exicom Tele-Systems Limited (NSE: EXICOM), one of India's leading EV charging and critical power…

4 months ago

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in…

4 months ago

Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue CINCINNATI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Quipt Home…

4 months ago